6505--Buprenorphine/Naloxone Sublingual Tablet

Closed Solicitation Posted

This opportunity was awarded. See the award notice from .

Solicitation number
36E79721R0001
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

Notice details come from SAM.gov. Updated .

About this opportunity

This solicitation seeks proposals to supply buprenorphine/naloxone sublingual tablets to the Department of Veterans Affairs National Acquisition Center for distribution through the VA and DOD Pharmaceutical Prime Vendor programs to VA, DOD, Bureau of Prisons, and Indian Health Service customers. The single-award contract would have a one-year base period and four one-year option periods. Offerors must propose pricing for both the 2mg/0.5mg and 8mg/2mg tablet formulations for all contract years. The closing date for proposals is November 10, 2020.

There is no set-aside designation. The NAICS code is 325412 and the PSC code was not provided. The estimated annual quantities are 145,412 bottles of the 2mg/0.5mg tablets and 275,699 bottles of the 8mg/2mg tablets. No budget range or current contractor information was included. Performance will occur nationwide as the tablets are distributed through the VA and DOD prime vendor networks.

Notice text

PRE-SOLICITATION NOTICE: The VA National Acquisition Center intends to issue Request for Proposal (RFP) 36E79721R0001 for an unrestrictive procurement for Buprenorphine HCL/Naloxone HCL Sublingual Tablets for the Department of Veterans Affairs (VA), Department of Defense (DOD), Bureau of Prisons (BOP), and Indian Health Service (IHS). The VA will award one contract to the responsible offeror who will be able to provide an uninterrupted source of supply for the contracted items. The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA s and DOD s respective Pharmaceutical Prime Vendor Programs. Offerors must state the exact name (name that appears on label) by which the drug will be supplied and have a unique NDC number. Solicitation # 36E79721R0001 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about October 27, 2020, with a tentative closing date of November 10, 2020. The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download at the following URL: https://beta.sam.gov/. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check this URL for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is Matthew Poulin. Questions can be emailed to: Matthew.Poulin@va.gov. Â

Â

The estimated annual requirements are as follows:Â

Â

Â

ITEM

DESCRIPTION

SIZE (TABS PER BOTTLE)

ESTIMATED ANNUAL REQUIREMENTS (BOTTLES)

1

BUPRENORPHINE HCL 2MG/NALOXONE HCL 0.5MG TAB,SUBLINGUAL

30

145,412

2

BUPRENORPHINE HCL 8MG/NALOXONE HCL 2MG TAB,SUBLINGUAL

30

275,699

Files

File Type Posted
36E79721R0001 0002.docx DOCX document
36E79721R0001 0001.docx DOCX document
36E79721R0001.docx DOCX document

Notice history

Notice Type Posted
6505--Buprenorphine/Naloxone Sublingual Tablets Award Award Notice
This notice Latest solicitation Solicitation
6505--Buprenorphine/Naloxone Sublingual Tablet Original Pre-Solicitation

Similar open opportunities

Opportunity Agency Set-aside Responses due
6505--Imatinib Tablets NAICS 325412 National Acquisition Center No set-aside
6505--Sacubitril/Valsartan Tablets (VA-27-00014055) NAICS 325412 National Acquisition Center No set-aside
Methylphenidate ER NAICS 325412 Medical Supply Chain No set-aside

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity